Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ninjin-yo-eito for hypotrophic older outpatients with anorexia
jRCTs031210674Completed
- Sponsor
- Kracie Pharmaceutical
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ninjinyoeito in Undernutrition and anorexia nervosa (AN), sponsored by Kracie Pharmaceutical. Primary endpoint: Change in CONUT score at 12 weeks. Started May 2022; status: completed.
02
Drugs
ninjinyoeito
03
Conditions
Undernutritionanorexia nervosa (AN)
Beyond the preview
Go deeper on jRCTs031210674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210674.